Abstract
The main achievements in the development of methods for the design of semisynthetic antibiotics of a new generation belonging to the group of polycyclic glycopeptides directed against infections caused by multidrug-resistant bacteria and dangerous human and animal viruses are reviewed. The review is focused on the results obtained at the Gauze Institute in the area of chemical modification of natural antibiotics (eremomycin, vancomycin, teicoplanin, etc.) directed toward modification of their antibacterial and/or antiviral activity. A special emphasis is placed on the study of the mechanisms of action of these antibiotics, which could be the basis of a rational approach to their chemical modification involving the transformation of the inner binding pocket and the peripheral regions of the molecules that participate in the formation of their complexes with targets. The recently discovered antiviral activity of modified glycopeptides antibiotics is also discussed. A possibility of obtaining new highly active anti-HIV-1 and anti-HIV-2 preparations on the basis of hydrophobic derivatives of the aglycones of glycopeptide antibiotics was demonstrated. New semisynthetic derivatives of antibiotics that exhibit a high antibacterial activity in vivo, have good pharmacological characteristics, and are promising for practical use are described.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AR:
-
amino acid residue
- DPPA:
-
diphenylphosphoryl azide
- EC50 :
-
the concentration of antibiotic necessary for the protection of 50% human T lymphocytes from HIV-1 and HIV-2 viruses μM)
- EDC:
-
ethyldimethylaminopropyl carbodiimide
- GISA:
-
staphylococci with an intermediate resistance to glycopeptides
- GINA:
-
Gause Institute of New Antibiotics
- GSE and GRE:
-
glycopeptidesensitive and glycopeptide-resistant enterococci
- HBTU:
-
(benzotriazol-1-yl)-1,1,3,3-bistetramethyleneuronium hexafluoro-phosphate; Lac, lactic acid
- MIC:
-
minimal inhibitory concentration of antibiotic (μg/ml)
- Mur:
-
muramic acid
- IC50 :
-
the concentration of antibiotic that inhibits the activity of enzymes responsible for the synthesis of peptidoglycan by 50% (μM)
- PyBOP:
-
(benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate
- TBTU:
-
(benzotriazol-1-yl)-1,1,3,3-bistetramethyleneuronium tetrafluoroborate
References
Walsh, C., Antibiotics: Actions, Origins, Resistance, Washington, DC: ASM, 2003.
Preobrazhenskaya, M.N. and Olsufyeva, E.N., Expert Opinion on Therapeutic, Patents, 2004, vol. 14, pp. 141–173.
Trenin, A.S. and Olsuf’eva, E.N., Bioorg. Khim., 1997, vol. 23, pp. 851–867 [Russ. J. Bioorg. Chem. (Engl. Transl.), 1997, vol. 23, pp. 757–772].
Pavlov, A.Yu. and Preobrazhenskaya, M.N., Bioorg. Khim., 1998, vol. 24, pp. 644–662 [Russ. J. Bioorg. Chem. (Engl. Transl.), 1998, vol. 24, pp. 570–587].
Printsevskaya, S.S., Olsuf’eva, E.N., Lazhko, E.I., and Preobrazhenskaya, M.N., Bioorg. Khim., 2002, vol. 28, pp. 79–88 [Russ. J. Bioorg. Chem. (Engl. Transl.), 2002, vol. 28, pp. 65–73].
Pavlov, A.Yu., Olsuf’eva, E.N., Miroshnikova, O.V., Reznikova, M.I., Lazhko, E.I., Malabarba, A., Chabatti, R., and Preobrazhenskaya, M.N., Bioorg. Khim., 1997, vol. 23, pp. 410–421 [Russ. J. Bioorg. Chem. (Engl. Transl.), 1997, vol. 23, pp. 383–393].
Printsevskaya, S.S., Pavlov, A.Y., Olsufyeva, E.N., Mirchink, E.P., Isakova, E.B., Reznikova, M.I., Goldman, R.C., Brandstrom, A.A., Baizman, E.R., Longley, C.B., Sztaricskai, F., Batta, G., and Preobrazhenskaya, M.N., J. Med. Chem., 2002, vol. 45, pp. 1340–1345.
Printsevskaya, S.S., Solovieva, S.E., Olsufyeva, E.N., Mirchink, E.P., Isakova, E.B., De Clercq, E., Balzarini, J., and Preobrazhenskaya, M.N., J. Med. Chem., 2005, vol. 45, pp. 3885–3889.
Malabarba, A., Ciabatti, R., Maggini, M., Ferrari, P., Colombo, L., and Denaro, M., J. Org. Chem., 1996, vol. 61, pp. 2151–2157.
Berdnikova, T.F., Lomakina, N.N., Olsuf’eva, E.N., Aleksandrova, L.G., and Malkova, I.V., Antibiot. Khimioter., 1991, vol. 36, pp. 28–31.
Olsufyeva, E.N., Berdnikova, T.F., Miroshnikova, O.V., Reznikova, M.I., and Preobrazhenskaya, M.N., J. Antibiot., 1999, vol. 52, pp. 319–324.
Pavlov, A.Y., Lazhko, E.I., and Preobrazhenskaya, M.N., J. Antibiot., 1996, vol. 50, pp. 509–513.
Printsevskaya, S.S., Pavlov, A.Y., Olsufyeva, E.N., Mirchink, E.P., and Preobrazhenskaya, M.N., J. Med. Chem., 2003, vol. 46, pp. 1204–1209.
Pavlov, A.Y., Preobrazhenskaya, M.N., Malabarba, A., and Ciabatti, R., Abstracts of Papers, 1st Intern. Conference on Chemistry of Antibiotics and Related Microbial Products, Bologna (Italy), 1998, p. 13.
Goldman, R.C., Baizman, E.R., Longley, C.B., and Branstrom, A., FEMS Microlett., 2000, vol. 183, pp. 209–214.
Pavlov, A.Y., Miroshnikova, O.V., Printsevskaya, S.S., Olsufyeva, E.N., Preobrazhenskaya, M.N., Goldman, R.C., Branstrom, A.A., Baizman, E.R., and Longley, C.B., J. Antibiot., 2001, vol. 54, pp. 455–459.
Preobrazhenskaya, M.N., Olsufyeva, E.N., Miroshnikova, O.V., Printsevskaya, S.S., Plattner, J.J., and Chu, D., Abstracts of Papers, 45 Intern. Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005, F-1227, p. 190.
Olsuf’eva, E.N., Berdnikova, T.F., Dokshina, N.Yu., Lomakina, N.N., Orlova, G.I., Malkova, I.V., and Prozorova, I.N., Antibiot. Khimioter., 1989, vol. 34, pp. 352–358.
Cooper, R.D.G., Snyder, N.J., Zweifel, M.J., Staszak, M.A., Rodrigues, M.J., Huff, B.E., and Thomphson, R.C., J. Antibiot., 1996, vol. 49, pp. 575–581.
Pavlov, A.Yu., Olsuf’eva, E.N., Berdnikova, T.F., Aleksandrova, L.G., Preobrazhenskaya, M.N., and Malkova, I.V., Bioorg. Khim., 1991, vol. 17, pp. 857–861.
Pavlov, A.Y., Berdnikova, T.F., Olsufyeva, E.N., Malkova, I.V., Preobrazhenskaya, M.N., and Risbridger, G.D., J. Antibiot., 1994, vol. 47, pp. 225–232.
Pavlov, A.Y., Berdnikova, T.F., Olsufyeva, E.N., Miroshnikova, O.V., Filipposyanz, S.T., Preobrazhenskaya, M.N., Sottani, C., Colombo, L., and Goldstein, B.P., J. Antibiot., 1996, vol. 49, pp. 194–198.
Miroshnikova, O.V., Printsevskaya, S.S., Olsufyeva, E.N., Pavlov, A.Y., Nilius, A., Hensey-Rudloff, D., and Preobrazhenskaya, M.N., J. Antibiot., 2001, vol. 54, pp. 455–459.
Maples, K., Plattner, J.J., Chu, D., Preobrazhenskaya, M.N., Olsufyeva, E.N., Printsevskaya, S.S., Solovyeva, S.E., Lovchik, J., and Lyons, R., Abstracts of Papers, 45 Intern. Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005, F-2073, p. 230.
Pavlov, A.Y., Berdnikova, T.F., Olsufyeva, E.N., Lazhko, E.I., Malkova, I.V., Preobrazhenskaya, M.N., Tesla, R.T., and Petersen, P.J., J. Antibiot., 1993, vol. 46, pp. 1731–1739.
Sharman, G.J. and Williams, D.H., Chem. Commun., 1997, pp. 723–724.
Allen, N.E. and Nicas, T., FEBS Microbiol. Rev., 2003, vol. 26, pp. 511–532.
Olsufyeva, E.N., Joergensen, P., Mirgorodskaya, O.A., Pavlov, A.Y., Miroshnikova, O.V., and Preobrazhenskaya, M.N., Abstracts of Papers, 1st Intern. Conference on Chemistry of Antibiotics and Related Microbial Products. Bologna (Italy), 1998, Abstr. PC12.
Mirgorodskaya, O.A., Olsuf’eva, E.N., Kolume, D.E., Iorgensen, E.D.D., Roepstorf, P., Pavlov, A.Yu., Miroshnikova, O.V., and Preobrazhenskaya, M.N., Bioorg. Khim., 2000, vol. 26, pp. 630–639; Rus. J. Bioorg. Chem., 2000, vol. 26, pp. 566–575.
Batta, G., Sztaricskai, F., Makarova, M.O., Gladkikh, E.G., Rogozheva, V.V., and Berdnikova, T.F., Chem. Commun., 2001, pp. 501–502.
Kim, J.S., Cegelsky, L., Preobrazhenskaya, M., and Schaefer, J., Biochemistry, 2006, vol. 45, pp. 5235–5250.
Chen, Z., Onishi, H.R., Kohler, J., Silver, L.L., Kerns, R., Fukuzawa, S., Thompson, C., and Kahne, D., Science, 1999, vol. 284, pp. 507–511.
Leimkuhler, C., Chen, L., Barrett, D., Panzone, G., Sun, B., Falcone, B., Oberthur, M., Donadio, S., Walker, S., and Kahne, D., J. Am. Chem. Soc., 2005, vol. 127, pp. 3250–3251.
Balzarini, J., Pannecouque, C., De Clercq, E., Pavlov, A.Y., Printsevskaya, S.S., Miroshnikova, O.V., Reznikova, M.I., and Preobrazhenskaya, M.N., J. Med. Chem., 2003, vol. 46, pp. 2755–2764.
Printsevskaya, S.S., Solovieva, S.E., Olsufyeva, E.N., Mirchink, E.P., Isakova, E.B., De Clercq, E., Balzarini, J., and Preobrazhenskaya, M.N., J. Med. Chem., 2005, vol. 48, pp. 3885–3890.
Preobrazhenskaya, M.N., Printsevskaya, S.S., Olsufyeva, E.N., Solovyeva, S.E., De Clercq, E., and Balzarini, J., Drug of the Future 2004, vol. 29,Suppl. A, Prous. J.R., Ed., Prous Science Barcelona-Philadelphia, XVIII Int. Symp. on Medicinal Chemistry, 2004, Sweden, Poster 267, p. 375.
De Clercq, E., J. Med. Chem., 2005, vol. 48, pp. 1297–1313.
Matsuzak, K., Ikeda, H., Ogino, T., Matsumoto, A., Woodruff, H.B., Tanaka, H., and Omura, S., J. Antibiot., 1994, vol. 47, pp. 1173–1174.
Naruse, N., Tenmyo, O., Kobaru, S., Hatori, M., Tomita, K., Hamigishi, Y., and Oki, T., J. Antibiot., 1993, vol. 46, pp. 1804–1811.
Singh, S.B., Jayasuriya, H., Salituro, G.M., Zink, D.L., Shafiee, A., Heimbuch, B., Silverman, K.C., Lingham, R.B., Genniloud, O., Teran, A., Vilella, D., Felock, P., and Hazuda, D., J. Nat. Prod., 2001, vol. 64, pp. 874–882.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.N. Olsuf’eva, M.N. Preobrazhenskaya, 2006, published in Bioorganicheskaya Khimiya, 2006, Vol. 32, No. 4, pp. 339–359.
Rights and permissions
About this article
Cite this article
Olsuf’eva, E.N., Preobrazhenskaya, M.N. Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics. Russ J Bioorg Chem 32, 303–322 (2006). https://doi.org/10.1134/S1068162006040017
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1134/S1068162006040017